全文获取类型
收费全文 | 10045篇 |
免费 | 366篇 |
国内免费 | 55篇 |
专业分类
耳鼻咽喉 | 123篇 |
儿科学 | 152篇 |
妇产科学 | 94篇 |
基础医学 | 1176篇 |
口腔科学 | 161篇 |
临床医学 | 551篇 |
内科学 | 2392篇 |
皮肤病学 | 170篇 |
神经病学 | 846篇 |
特种医学 | 464篇 |
外科学 | 1623篇 |
综合类 | 41篇 |
预防医学 | 243篇 |
眼科学 | 397篇 |
药学 | 687篇 |
中国医学 | 10篇 |
肿瘤学 | 1336篇 |
出版年
2023年 | 34篇 |
2022年 | 100篇 |
2021年 | 153篇 |
2020年 | 70篇 |
2019年 | 110篇 |
2018年 | 179篇 |
2017年 | 138篇 |
2016年 | 207篇 |
2015年 | 196篇 |
2014年 | 265篇 |
2013年 | 340篇 |
2012年 | 540篇 |
2011年 | 584篇 |
2010年 | 347篇 |
2009年 | 297篇 |
2008年 | 613篇 |
2007年 | 672篇 |
2006年 | 682篇 |
2005年 | 705篇 |
2004年 | 683篇 |
2003年 | 613篇 |
2002年 | 691篇 |
2001年 | 157篇 |
2000年 | 135篇 |
1999年 | 170篇 |
1998年 | 153篇 |
1997年 | 171篇 |
1996年 | 124篇 |
1995年 | 121篇 |
1994年 | 113篇 |
1993年 | 105篇 |
1992年 | 91篇 |
1991年 | 74篇 |
1990年 | 77篇 |
1989年 | 67篇 |
1988年 | 65篇 |
1987年 | 50篇 |
1986年 | 53篇 |
1985年 | 55篇 |
1984年 | 53篇 |
1983年 | 43篇 |
1982年 | 40篇 |
1981年 | 32篇 |
1980年 | 31篇 |
1979年 | 36篇 |
1978年 | 21篇 |
1977年 | 35篇 |
1976年 | 25篇 |
1975年 | 17篇 |
1969年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
102.
Yuri Takahashi Yasuo Miyoshi Chie Takahata Natsumi Irahara Tetsuya Taguchi Yasuhiro Tamaki Shinzaburo Noguchi 《Clinical cancer research》2005,11(4):1380-1385
PURPOSE: LATS1 and LATS2 are tumor suppressor genes implicated in the regulation of cell cycle. Methylation status of the promoter regions of these genes as well as its correlation with their mRNA levels were studied in human breast cancers. Correlation of LATS1 and LATS2 mRNA levels with clinicopathologic characteristics of breast tumors were also studied. EXPERIMENTAL DESIGN: Methylation status of promoter regions of LATS1 and LATS2 was studied by a methylation-specific PCR and mRNA expression levels of LATS1 and LATS2 were determined by a real-time PCR assay in 30 breast cancers. In addition, correlation of LATS1 and LATS2 mRNA levels with clinicopathologic characteristics was studied in 117 breast cancers. RESULTS: Methylation-specific PCR showed that of 30 tumors, LATS1 promoter region was hypermethylated in 17 tumors (56.7%) and LATS2 promoter region was hypermethylated in 15 (50.0%) tumors. LATS1 mRNA levels in breast tumors with hypermethylation (2.15 +/- 0.37, mean +/- SE) were significantly (P < 0.01) lower than those without hypermethylation (6.09 +/- 1.38), and LATS2 mRNA levels in breast tumors with hypermethylation (1.42 +/- 0.66) were also significantly (P < 0.01) lower than those without hypermethylation (3.10 +/- 1.00). The decreased expression of LATS1 or LATS2 mRNA was significantly associated with a large tumor size, high lymph node metastasis, and estrogen receptor and progesterone receptor negativity. Furthermore, the decreased expression of LATS1 mRNA, but not LATS2 mRNA, was significantly (P < 0.05) associated with a poor prognosis. CONCLUSIONS: Hypermethylation of the promoter regions of LATS1 and LATS2 likely plays an important role in the down-regulation of their mRNA levels in breast cancers, and breast cancers with a decreased expression of LATS1 or LATS2 mRNA levels have a biologically aggressive phenotype. 相似文献
103.
Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species. 总被引:5,自引:0,他引:5
Tomonori Nakazato Keisuke Ito Yasuo Ikeda Masahiro Kizaki 《Clinical cancer research》2005,11(16):6040-6049
PURPOSE: Green tea polyphenol, (-)-epigallocatechin-3-gallate, has been shown to inhibit cellular proliferation and induce apoptosis of various cancer cells. The aim of this study was to investigate the possibility of (-)-epigallocatechin-3-gallate as a novel therapeutic agent for the patients with B-cell malignancies including multiple myeloma. EXPERIMENTAL DESIGN: We investigated the effects of (-)-epigallocatechin-3-gallate on the induction of apoptosis in HS-sultan as well as myeloma cells in vitro and further examined the molecular mechanisms of (-)-epigallocatechin-3-gallate-induced apoptosis. RESULTS: (-)-Epigallocatechin-3-gallate rapidly induced apoptotic cell death in various malignant B-cell lines in a dose- and time-dependent manner. (-)-Epigallocatechin-3-gallate-induced apoptosis was in association with the loss of mitochondrial transmembrane potentials (Deltapsim); the release of cytochrome c, Smac/DIABLO, and AIF from mitochondria into the cytosol; and the activation of caspase-3 and caspase-9. Elevation of intracellular reactive oxygen species (ROS) production was also shown during (-)-epigallocatechin-3-gallate-induced apoptosis of HS-sultan and RPMI8226 cells as well as fresh myeloma cells. Antioxidant, catalase, and Mn superoxide dismutase significantly reduced ROS production and (-)-epigallocatechin-3-gallate-induced apoptosis, suggesting that ROS plays a key role in (-)-epigallocatechin-3-gallate-induced apoptosis in B cells. Furthermore, a combination with arsenic trioxide (As2O3) and (-)-epigallocatechin-3-gallate significantly enhanced induction of apoptosis compared with As2O3 alone via decreased intracellular reduced glutathione levels and increased production of ROS. CONCLUSIONS: (-)-Epigallocatechin-3-gallate has potential as a novel therapeutic agent for patients with B-cell malignancies including multiple myeloma via induction of apoptosis mediated by modification of the redox system. In addition, (-)-epigallocatechin-3-gallate enhanced As2O3-induced apoptosis in human multiple myeloma cells. 相似文献
104.
Yumiko Kasugai Hiroyuki Tagawa Yoshihiro Kameoka Yasuo Morishima Shigeo Nakamura Masao Seto 《Clinical cancer research》2005,11(23):8265-8272
PURPOSE: Increases in gene dosage through DNA amplification represents a common feature of many tumors and can result in the up-regulation of tumor-promoting genes. Our recent genome-wide, array-based comparative genomic hybridization analysis of 66 cases of diffuse large B-cell lymphoma found that genomic gain of 6p21 was observed in as many as 17 cases, including 14 cases with low-level copy number gain and three cases with high-level copy number gains (amplifications). EXPERIMENTAL DESIGN AND RESULTS: To identify the target gene(s) for 6p21 amplification, we constructed a detailed amplicon map at the region of genomic amplification with the aid of high-resolution contig array-based comparative genomic hybridization glass slides, consisting of contiguously ordered bacterial artificial chromosome/P1-derived artificial chromosome clones covering 3 Mb throughout the 6p21 amplification region. Alignment of the amplifications identified a minimally overlapping 800 kb segment containing 15 genes. Quantitative expression analysis of the genes from both patient samples and the SUDHL9 cell line revealed that CCND3 and BYSL (1.9 kb telomeric to the CCND3 gene locus) are the targets of 6p21 genomic gain/amplification. CONCLUSIONS: Although it is known that t(6;14)(p21;q32) induces aberrant overexpression of CCND3 in B-cell malignancies, we were able to show that CCND3, which encodes the cyclin D family member protein that controls the G1-S phase of cell cycle regulation, can also be a target of genomic gain/amplification. Overexpression of CCND3 through genomic amplification is likely to lead to aberrant cell cycle control, although the precise biological role of BYSL with respect to tumorigenesis remains to be determined. 相似文献
105.
Takahiro Zenda MD Takaharu Masunaga Bungo Fuwa Toshihide Okada Yasuo Ontachi Yukio Kondo Shinji Nakao Hiroshi Minato 《Journal of gastrointestinal cancer》2005,36(2):113-119
A 49-yr-old Japanese woman underwent upper gastrointestinal endoscopy because of nonspecific dyspepsia. Endoscopy revealed a flat elevated lesion about 15 mm in diameter adjacent to the duodenal papilla, the surface of which was uneven and covered with whitish granules. Based on the results of histological examination with immunohistochemistry (positive for CD10, CD20, CD79a, and bcl-2 protein, negative for CD5 and cyclin D1), a diagnosis of grade 1/3 follicular lymphoma was established. Systemic staging examinations suggested the lymphoma was restricted to the mucosa and superficial portion of the submucosa in the duodenal wall. The patient was treated with a combination of CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisolone) and monoclonal anti-CD20 antibody (rituximab), in addition to radiotherapy. After six courses of this combination chemotherapy, complete regression of the lymphoma was observed. Although reports of small duodenal lymphoma (<20 mm or localized to the mucosa or submucosa) are extremely rare, the features of this case are characteristic of small duodenal lymphoma in terms of evolution around the ampulla of Vater, low-grade follicular type, occurrence in a women, occurrence in the fourth decade of life, and favorable outcome, and this type of tumor may need to be distinguished by pathogenesis and clinical behavior from various other gastrointestinal lymphomas. 相似文献
106.
107.
Mami Hiraoka Shigeo Takashima Yoshiko Wakihara Yuji O. Kamatari Kaori Shimizu Ayaka Okada Yasuo Inoshima 《Viruses》2022,14(5)
Enzootic bovine leukosis (EBL) is a disease caused by bovine leukemia virus (BLV); only a small percentage of BLV-infected cattle develop EBL and present with B-cell lymphosarcoma. There is no vaccine against BLV, treatment for EBL, or method for predicting the possibility of EBL onset, thus making EBL control difficult. Herein, to explore biomarkers for EBL in milk, we examined the mRNA profiles of small extracellular vesicles (sEVs) in milk from four BLV-uninfected and four EBL cattle by microarray analysis. It was revealed that 14 mRNAs were encapsulated in significantly higher quantities, and these mRNAs were therefore selected as biomarker candidates. Primers for these mRNAs were designed, and nine primer sets were available for quantitative real-time PCR. Nine mRNAs were evaluated for their availability as biomarkers for EBL using sEVs from newly-collected milk of 7 uninfected and 10 EBL cattle. The quantities of eight mRNAs (TMEM156, SRGN, CXCL8, DEFB4A, FABP5, LAPTM5, LGALS1, and VIM) were significantly higher in milk sEVs of EBL cattle than in those of uninfected cattle. Therefore, our findings indicate that these eight mRNAs in milk sEVs can be used as potential EBL biomarkers with combination use, although single mRNA use is not enough. Consequently, cattle at risk of EBL onset can be identified by monitoring the fluctuation in quantities of these mRNAs in milk before they develop EBL. 相似文献
108.
Purpose
We reviewed the indications, safety, and efficacy of photodynamic therapy with verteporfin in various macular diseases and vasculopathies, which are common in Asian populations, and compared the outcomes of photodynamic therapy in Asian patients with the outcomes in Caucasian patients.Methods
Relevant clinical and laboratory original articles, case reports, and review articles that have been published in the literature between January 1999 and October 2004 were searched in Medline. The potential differences in the response to photodynamic therapy between Asian and Caucasian patients were evaluated. Articles in foreign languages with English abstracts were included.Results
Macular diseases commonly seen in Asian populations, including choroidal neovascularization (CNV) of age-related macular degeneration, secondary to pathologic myopia or from an idiopathic cause, and choroidal vasculopathies such as central serous chorioretinopathy and polypoidal choroidal vasculopathy were included in the review. The results were tabulated and the differences with Caucasian populations were compared and highlighted.Conclusion
Photodynamic therapy has been found to be an effective and noninvasive treatment for various subfoveal CNV and choroidal vasculopathies of the macula. Diverse behavior in different ethnic groups is observed. Jpn J Ophthalmol 2006;50:161–169 © Japanese Ophthalmological Society 2006 相似文献109.
窄叶鲜卑花的化学成分 总被引:9,自引:0,他引:9
目的:研究窄叶鲜卑花(Sibiraea angustata)的化学成分。方法:采用柱色谱进行分离纯化.通过理化方法和光谱分析鉴定化合物结构。结果:从窄叶鲜卑花中分离得到6个化合物,经鉴定为十八酸(octadecanoic acid)(Ⅰ),lanosta-8,24-dien-3-acetyloxy-26-oic acid(Ⅱ),胡萝卜甾醇(daucosteml)(Ⅲ),异阿魏酸(isoferulic acid)(Ⅳ),咖啡酸(caffeic acid)(Ⅴ),咖啡酸山梨醇酯(caffeic acid glucitd ester)(Ⅵ)。结论:以上化合物均为从窄叶鲜卑花中首次分得,其中化合物Ⅵ为新化合物。 相似文献
110.
Yasuo Yanagi Aya Iriyama Woo-Dong Jang Kazuaki Kadonosono 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2007,245(5):677-681
Background The purpose of the study was to investigate the brightness of the xenon/bandpass light in vitrectomy and assess its phototoxic
effects using A2E-laden retinal pigment epithelial (RPE) cells.
Methods The total luminous flux and spectral irradiance of 20- and 25-gauge endoilluminators connected to xenon lamps were measured
and compared to those of 20- and 25-gauge endoilluminators connected to a halogen lamp. In vitro, A2E-laden cells were evenly
exposed to xenon/bandpass light for 5 to 30 min positioned at 1 cm and 2 cm for a standard light probe and an implantable
“chandelier” light probe, respectively, above the cells, and the cell viability was assessed using WST-1 assay. The cell viability
was compared with cells exposed to 30 min of halogen light projected through a 20-gauge endoilluminator.
Results The maximal total luminous flux of xenon/bandpass light emitted through the 20-gauge endoilluminator was 2.8 times higher
than that of the halogen light. The total luminous flux of the 25-gauge endoilluminators was 0.6-1.1 times greater than the
20-gauge endoilluminators connected to the halogen light. The viability of the A2E-laden cells after exposure to the xenon/bandpass
light was no different than that of the cells exposed to the halogen light when the total luminous flux of these lights was
at the same level. Xenon/bandpass light from an implantable “chandelier” light probe induced A2E-mediated RPE damage to a
similar extent as that of the halogen light through a 20-gauge endoilluminator.
Conclusions A2E-mediated phototoxicity of xenon/bandpass light is comparable to that of halogen light. 相似文献